The Rising Clinical Trials Drive the Human Embryonic Stem Cells Market Growth


Human Embryonic Stem Cells Market
Human Embryonic Stem Cells Market 


Human Embryonic Stem Cells Market is segmented By Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, and Toxicology Testing) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

The global Human Embryonic Stem Cells Market is estimated to be valued at US$ 1,152.2 Million in 2022 and is expected to exhibit a CAGR of 9.2%over the forecast period as highlighted in a new report published by Coherent Market Insights.

Market Overview

Human Embryonic Stem Cells are the body's raw substances — cells from which all the tissues with particular services are created. Under the proper situations in the body or a lab, Human Embryonic Stem Cells fragment to create more cells known as daughter cells. These daughter cells are either new stem cells or particular cells with a very particular services, such as blood cells, brain tissues, cardiac muscle tissues or bone cells. No other tissues in the body has the direct capability to create new cell forms.

Competitive Landscape:

Key players involved in the growth of global Human Embryonic Stem Cells Market are Lineage Cell Therapeutics Inc, Thermo Fisher Scientific, ViaCyte, Inc., Merck KGaA, STEMCELL Technologies Inc, PeproTech Inc, PromoCell GmbH, and Astellas Pharma Inc.

Market Key Drivers:

The increasing number of clinical trials and high demand of stem cell therapy is expected to augment the growth of the global Human Embryonic Stem Cells Market. For instance, as per WHO, by 24 November 2022, around 434 thousand clinical trials were conducted across the globe.

The investment by government for the growth of regenerative medicines is anticipated to drive the growth of the global Human Embryonic Stem Cells Market. For instance, in June 2020, the Australian Government invested US$ 5.9 million for eight medical research developments to search new and innovative stem cell therapies for inveterate diseases, such as leukemia, PD, and epilepsy.

Coid-19 Impact Analysis:

The Covid-19 outbreak has positively affected the growth of the global Human Embryonic Stem Cells Market due to the increasing clinical studies and the rising adoption of stem cell therapies across the globe. With relation to COVID-19, government officials in several regions, research institutes, and several biotech and pharmaceutical industry are aiming on efficient and rapid techniques for the instant diagnosis of COVID-19.

Key Takeaways:

The global Human Embryonic Stem Cells Market is expected to exhibit a CAGR of 9.2 % during the forecast period owing to the rising acquisitions and plans by the key players to expand its product. For instance, in February 2020, the GIOSTAR introduced a new stem cell and cancer research and therapy clinic or lab in Chandigarh, India.

Among regions, North America, Asia Pacific and Europe anticipated to witness robust growth in the global Human Embryonic Stem Cells Market due to rising adoption of stem cell therapy, increasing clinical trials, rising demand for stem cell therapy biology and acquisitions by the key players for the expansion of the product. For instance, in September 2019, the US Food and Drug Administration granted clinical trials, which determined the usage of stem cells.

Comments

Popular posts from this blog

Refinery Catalysts are Important Components of a Petroleum Refinery

Wearable Injector are Devices Which Adhere to the Body and Help in Administering Drug to the Patient

Global Flocculant And Coagulant Market Is Estimated To Witness High Growth Owing To Increasing Demand For Water Treatment Applications